Log In
Print this Print this

GLA-SE (G100) (formerly GL-100, ID-G100)

  Manage Alerts
Collapse Summary General Information
Company Immune Design Corp.
DescriptionToll-like receptor 4 (TLR4) agonist
Molecular Target Toll-like receptor 4 (TLR4)
Mechanism of ActionVaccine; Immunotherapy
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today